Abstract:Background and aim: Hypoxia invariably develops as solid tumors enlarge, and there are unique cellular adaptations to ensure tumor survival in these conditions.Our previous work demonstrated a key role for K-RAS in the induction of angiogenic factors VEGF and IL-8 in hypoxic conditions.We have identified adrenomedullin (ADM) as a novel target of K-RAS in hypoxia and sought to determine its functional role in CRC.Methods: We performed cDNA microarray studies using DKS-5 cells with a K-RAS (D13) mutation and DKO-3 cells in which the mutant K-RAS oncogene was knocked-out.ADM expression was verified by Q-PCR and ELISA in CRC cells by knocking-down or overexpressing mutant K-RAS.ADM expression in 56 human colorectal tumors (K-RAS mutant=14, WT=42) was evaluated by immunohistochemistry.The functional roles on cell migration, invasion, and proliferation were determined after exogenous administration of ADM peptide or siRNA knockdown of ADM In Vitro.Results: Microarrays demonstrated that ADM was significantly upregulated in mutant K-RAS (D13) cells relative to isogenic WT K-RAS cells in hypoxic conditions.qPCR and ELISA assays confirmed the induction of ADM mRNA (17 fold) and protein (4.5 fold) by the combination of K-RAS and hypoxia.The hypoxic induction of ADM was reduced 70-89% when K-RAS was knocked-down in DLD1, HCT116, and SW480 cell lines.Stable expression of mutant K-RAS in Caco2 cells induced ADM expression 2.4 fold.The induction of ADM by K-RAS and hypoxia depended upon HIF-1, as this induction was blocked by knockdown of HIF-1alpha.In addition, inhibition of PI3K but not MEK1 suppressed the induction both HIF-1 and ADM in hypoxic conditions.Administration of 200 nmol/L ADM stimulated migration (217% ± 42%, p<0.001), invasion (195% ± 4.0%, p<0.001) and proliferation (146% ± 6.0%, p<0.01) of SW480 cells.Interestingly, ADM induced VEGF levels 1.5 fold, and knockdown of ADM suppressed VEGF levels to 32% of baseline.Finally, a significant correlation was observed between ADM protein staining and the K-RAS genotype in human CRC samples, with moderate to strong staining of ADM seen in 71% of K-RAS mutant tumors vs. 40% of K-RAS WT tumors (p<0.05).Conclusion: Adrenomedullin is a novel target of K-RAS and hypoxia in colon cancer.K-RAS regulates the hypoxic induction of ADM through the PI3K and HIF-1 pathways.In addition to stimulating colon cancer cell invasion and growth, ADM can regulate angiogenesis through the induction of VEGF.Collectively, these findings highlight the importance of K-RAS and ADM in colon tumor survival in hypoxic conditions.

Hypoxia-induced apoptosis is blocked by adrenomedullin via upregulation of Bcl-2 in human osteosarcoma cells

Downregulation of Adrenomedullin Leads to the Inhibition of the Tumorigenesis Via VEGF Pathway in Human and Nude Mice Osteosarcoma Models.

Adrenomedullin is a Novel K-RAS Target Gene That Regulates Cellular Invasion and Angiogenesis in Hypoxia

Elevated expression of adrenomedullin is correlated with prognosis and disease severity in osteosarcoma

Honokiol Induces Apoptosis and Autophagy Via the ROS/ERK1/2 Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo.

Antisense C - Myc Sensitizes Osteosarcoma Cells to Cisplatin- Induced Apoptosis

X-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells.

Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth

Hypoxia promotes drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signaling.

Bortezomib Sensitizes Human Osteosarcoma Cells to Adriamycin‐induced Apoptosis Through ROS‐dependent Activation of P‐eif2α/atf4/chop Axis

Adrenomedullin and Its Expression in Cancers and Bone. A Literature Review.

Metabolism Of Reactive Oxygen Species In Osteosarcoma And Potential Treatment Applications

Shikonin Promotes Adriamycin-Induced Apoptosis by Upregulating Caspase-3 and Caspase-8 in Osteosarcoma

Smac Mimetic Sm-164 Enhanced Adriamycin Induced Apoptosis And Cell Cycle Arrest In Osteosarcoma Cell Line Hos

2-Bromopalmitate Sensitizes Osteosarcoma Cells to Adriamycin-Induced Apoptosis Via the Modulation of CHOP.

Arsenic trioxide inhibits the growth of Adriamycin resistant osteosarcoma cells through inducing apoptosis

Hypoxia Inhibitor Combined with Chemotherapeutic Agents for Antitumor and Antimetastatic Efficacy against Osteosarcoma

Oleanolic acid induces osteosarcoma cell apoptosis by inhibition of Notch signaling.

Experimental study of the anti-apoptosis effect of XBP1s on osteosarcoma cells under CoCl2-induced hypoxic condition

Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2

Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion